1.900
+0,00%
2026-10-19
Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +49.4% | +126.1% | 3 / 3 | -63.3% | +67.65 pp | -12.95 pp | +13.3% | 1.87 | 1.30 | 27,9 | −63,3% | −33,5 | +58,9% | 1.30 | 3.05 | −57,5% |
| Pts | 8 | 12 | 12 | 0 | 12 | 0 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 1.900 (close price on 2026-10-19)EPS (TTM): 1.466
Financial charts
1.Revenue & growth
VND bn27,9Q2/26
1.Revenue & growth
VND bn27,9Q2/26
2.Profit & growth
VND bn-33,5Q2/26
3.Profit mix (Penman)
VND bn89,2Q2/26
4.Margins & cost structure
%17.7%Q2/26
5.Returns & cash cycle
% · days1.0%Q2/26
6.Earnings quality & cash
VND bn91,3Q2/26
7.Asset structure
VND bn3.073Q2/26
8.Funding & debt health
VND bn · times3.073Q2/26
9.Revenue backlog
VND bn163Q2/26
10.Valuation
times · %1,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-370Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26